References
1. Hong Li Y, Marren A. Recurrent pregnancy loss: A summary of international evidence-based guidelines and practice. Aust J Gen Pract 2018; 47 (7): 432-6.
2. Green DM, O’Donoghue K. A review of reproductive outcomes of women with two consecutive miscarriages and no living child. J Obstet Gynaecol 2019; 39 (6): 816-21.
3. Practice Committee of the American Society for Reproductive M. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98 (5): 1103-11.
4. Homer HA. Modern management of recurrent miscarriage. Aust N Z J Obstet Gynaecol 2019; 59 (1): 36-44.
5. Henkel A, Shaw KA. Advances in the management of early pregnancy loss. Curr Opin Obstet Gynecol 2018; 30 (6): 419-24.
6. Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368 (9535): 601-11.
7. Monien S, Kadecki O, Baumgarten S, Salama A, Dorner T, Kiesewetter H. Use of heparin in women with early and late miscarriages with and without thrombophilia. Clin Appl Thromb Hemost 2009;15 (6): 636-44.
8. Luan X, Kang X, Li W, Dong Q. An investigation of the relationship between recurrent spontaneous abortion and memory T follicular helper cells. Am J Reprod Immunol 2017; 78 (5).
9. Qian J, Zhang N, Lin J, et al. Distinct pattern of Th17/Treg cells in pregnant women with a history of unexplained recurrent spontaneous abortion. Biosci Trends 2018; 12 (2): 157-67.
10. Yang F, Zheng Q, Jin L. Dynamic Function and Composition Changes of Immune Cells During Normal and Pathological Pregnancy at the Maternal-Fetal Interface. Front Immunol 2019; 10 : 2317.
11. Deshmukh H, Way SS. Immunological Basis for Recurrent Fetal Loss and Pregnancy Complications. Annu Rev Pathol 2019; 14 : 185-210.
12. Saini V, Arora S, Yadav A, Bhattacharjee J. Cytokines in recurrent pregnancy loss. Clin Chim Acta 2011; 412 (9-10): 702-8.
13. Jena MK, Nayak N, Chen K, Nayak NR. Role of Macrophages in Pregnancy and Related Complications. Arch Immunol Ther Exp (Warsz) 2019;67 (5): 295-309.
14. Zhang YH, He M, Wang Y, Liao AH. Modulators of the Balance between M1 and M2 Macrophages during Pregnancy. Front Immunol 2017;8 : 120.
15. Yao Y, Xu XH, Jin L. Macrophage Polarization in Physiological and Pathological Pregnancy. Front Immunol 2019; 10 : 792.
16. Lazarus AH, Crow AR. Mechanism of action of IVIG and anti-D in ITP.Transfus Apher Sci 2003; 28 (3): 249-55.
17. Brinc D, Denomme GA, Lazarus AH. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models? Curr Opin Hematol 2009; 16 (6): 488-96.
18. Carp H. Immunotherapy for recurrent pregnancy loss. Best Pract Res Clin Obstet Gynaecol 2019; 60 : 77-86.
19. Rasmark Roepke E, Bruno V, Nedstrand E, et al. Low-molecular-weight-heparin increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: a randomised controlled trial. Sci Rep 2019;9 (1): 12314.
20. Coopamah MD, Freedman J, Semple JW. Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist. Blood2003; 102 (8): 2862-7.
21. Crow AR, Lazarus AH. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?Transfus Med Rev 2008; 22 (2): 103-16.
22. Salama A. Emerging drugs for immune thrombocytopenia (ITP).Expert Opin Emerg Drugs 2017; 22 (1): 27-38.
23. Schumacher A, Sharkey DJ, Robertson SA, Zenclussen AC. Immune Cells at the Fetomaternal Interface: How the Microenvironment Modulates Immune Cells To Foster Fetal Development. J Immunol 2018;201 (2): 325-34.
24. Davis D, Kaufmann R, Moticka EJ. Nonspecific immunity in pregnancy: monocyte surface Fcgamma receptor expression and function. J Reprod Immunol 1998; 40 (2): 119-28.
25. Huang N, Chi H, Qiao J. Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases. Front Immunol 2020; 11 : 1023.
26. Pei CZ, Kim YJ, Baek KH. Pathogenetic factors involved in recurrent pregnancy loss from multiple aspects. Obstet Gynecol Sci 2019;62 (4): 212-23.
27. Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest2018; 128 (10): 4224-35.
28. Esteve-Sole A, Luo Y, Vlagea A, et al. B Regulatory Cells: Players in Pregnancy and Early Life. Int J Mol Sci 2018; 19 (7).
29. Matthiesen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 2012; 67 (4): 334-40.
30. Muyayalo KP, Li ZH, Mor G, Liao AH. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion. Am J Reprod Immunol 2018;80 (4): e13018.